Introduction
The clinical presentation of AIDS was first recognized in the USA in 1981 [1] . Two years later, the virus that caused AIDS, HIV was isolated [2] and commercial antibody tests became available in 1985 allowing for routine laboratory diagnosis. With the advent of these diagnostic tools came the ability to define and track the epidemic that soon evolved into a global pandemic. Thirty-years later, there have been 39 million HIV-related deaths, and 35 million people are infected with HIV worldwide [3] . The Centers for Disease Control and Prevention (CDC) estimate that more than 1.2 million individuals (age 13 and older) in the USA are currently infected with HIV, of which approximately 14% remain unaware of their infection [4] .
Emergency departments (EDs) serve as windows for their communities often revealing the state of public health, as a large portion of the populace visits them. In 2011 there were 136 million visits in the USA representing approximately 45 per 100 person-years [5] . The uninsured and publically insured are disproportionately represented [6] . The Johns Hopkins Hospital Emergency Department (JHH-ED) has served as both an observational window on the HIV epidemic for over 25 years, and as a pioneer in ED-based testing and linkage-to-care (LTC) programs [7] [8] [9] [10] [11] [12] [13] [14] .
Our first probative investigation occurred in 1986 where we studied critically ill and injured patients presenting to our ED with HIV infection [7] . The purpose was to gauge the extent of potential healthcare worker exposure to patients with unknown HIV infection in a high-risk practice setting. This and subsequent studies revealed the relative high rates of undocumented or unknown HIV infection [8] [9] [10] , as well as other blood-borne infections such as hepatitis B virus, hepatitis C virus [15] , and HTLV-I/II infections [16] . These seroepidemiological studies yielded critical information on the changing epidemiology of HIV within an inner-city population, and provided opportunity to assess the effectiveness of programmatic interventions critical to HIV diagnosis, LTC, and prevention activities. In this report, we document the changing nature of the local epidemic in Baltimore since 1987 seen through the lens of the JHH-ED, and assess the potential impact of a sustained ED-based testing and LTC program in our ongoing efforts to address the HIV epidemic in Baltimore.
Methods
The Johns Hopkins Hospital is a tertiary care academic hospital located in inner-city Baltimore, Maryland. The JHH-ED continues to serve a predominantly indigent population. Annual ED visits have ranged from 60 000 to 70 000 visits during the study periods. The data derived were from two types of data sources. All data reported were either exclusively identity-unlinked, or were concurrent with ED-based HIV-screening and LTC programs as described below.
Identity unlinked seroprevalence data
To assess general trends, data were abstracted from seven discrete identity-unlinked serosurveys, between 1987 and 2013, which included a total 18 144 adult JHH-ED patients in whom excess blood was available for testing. Data included trends in HIV, HIV viral load, HIV crosssectional annual incidence estimates, and antiretroviral treatment [8] [9] [10] [11] 13] . Data were abstracted from earlier studies, whereas some 2001-2013 data are presented here for the first time. The Johns Hopkins University School of Medicine Institutional Review Board approved all studies.
Methods for the identity-unlinked studies are detailed in previous reports [8] [9] [10] . Briefly, the identity-unlinked seroprevalence methodology involved collection of excess sera from all individuals who had blood drawn for any purpose, and assigning of a unique study code, devoid of any patient identifiers from the sera specimen. Patient-related data were collected in real time. Chart reviews were undertaken in a specific, structured manner [17] . All patient identifiers and other protected health information were irretrievably stripped after relevant patient-related data were collected from the chart review and prior to serologic analysis. Results of serologic analysis were merged to identifier-stripped dataset by the unique study code. Thus, no laboratory result could be traced back to any specific patient and was not available in the study database.
HIV-screening programmatic data
A rapid ED-based voluntary HIV-screening and LTC program, restricted only by CDC aged-based recommendations, has been in continuous existence since 2005 [13, 14, 18] . Laboratory testing protocols including methods for confirmation of HIV results are detailed in these reports [13, 14, 18] . Patients confirmed to be HIV positive were reported to the health department. Longitudinal follow-up regarding long-term retention to care, antiretroviral treatment, and viral suppression on individual HIV-positive patients identified from the screening program were not part of the screening/LTC program.
The LTC program evolved over time and is described in detail in the appropriate respective studies [19, 20] or programs [14, 18, 21, 22] . Briefly, prior to 1992 all of our studies were identity unlinked and thus no LTC. Since 1992, all confirmed HIV-positive patients were counseled as to options for medical care but a prearranged appointment (usually within 1-3 weeks) was arranged by co-operative agreement in the hospital's HIV (Moore) clinic. All protocols required trained program staff to carry out testing, counseling, and arrange for follow-up from the ED. The ED staff providing care did not participate in LTC arrangements at any time for screened patients. Prior to availability of point of care rapid testing (1992) (1993) (1994) (1995) , patients were given a $10 voucher to assist with transportation to return for initial results [19, 20] . Beginning in 2005, LTC referred patients received two phone calls reminders from program staff [14, 18, 21] . Beginning 2013 patients confirmed positive patients met with a clinical nurse from the HIV clinic while still in the ED, and guaranteed an appointment within one business day [22] .
Serologic analyses
Sera were tested by HIV enzyme immunoassays (ELISA) which differed by survey year as the technology evolved. Testing methodologies used in early surveys are described in previous publications [8] [9] [10] [11] . For the 2007 and 2013 surveys, the Genetic Systems third generation ELISA (BioRad, Redmond, Washington, USA) was used with western blot confirmation (BioRad). For the 2001 to 2013 surveys, samples with indeterminate and positive serologic results were then analyzed for HIV viral load using the Roche Amplicor v1.5 (limit of detection of 400 copies/ml; Roche, Indianapolis, Indiana, USA).
For both the 2007 and 2013 surveys, antiretroviral testing of serum was performed on all HIV-positive specimens with sufficient volume using HPLC-tandem mass spectrometry (2007) [23] and HPLC-high resolution accurate mass (HRAM) mass spectrometry (2013) [24] by the Clinical Pharmacology Laboratory and Pathology Reference Laboratory, respectively, at our institution. Antiretrovirals that were detected included lamivudine, emtricitabine, nevirapine, abacavir, tenofovir, zidovudine, efavirenz, raltegravir, amprenavir, maraviroc, darunavir, nelfinavir, tipranavir, indinavir, lopinavir, saquinavir, atazanavir, ritonavir, and rilpivirine.
HIV incidence testing was performed on samples from ED surveys between 2001 and 2013. Testing was performed using an algorithm that included the BED capture enzyme immunoassay assay (Calypte Biomedical, Portland, Oregon, USA; employing a cut off of less than 1.5 OD-n), BioRad avidity assay (employing the Genetic Systems 1/2 þ O ELISA; BioRad) (using an avidity index cut off of 40%), and viral load testing more than 400 copies/ml [25] . This testing algorithm has a window period of 101 days and a false recent rate of 0% [25] .
Data analysis
HIV-infected patients were categorized as known HIVinfected if they self-reported infection status or had documented HIV infection in the medical chart at their ED visit. Although the presence of antiretrovirals in blood specimens is only available from the 2007 and 2013 serosurveys, it is indicative of HIV diagnosis. However, for consistency across all survey years, these patients were not included in aggregate data, but are noted separately. Patients considered to have undiagnosed HIV infection were those who were identified as HIV positive by laboratory testing but not known to be HIV-infected.
Seroprevalence of HIV and corresponding 95% confidence intervals (CIs) for each serosurvey were calculated. Cross-sectional annual HIV incident point estimates and CIs were calculated using the methods previously published [26] . Demographic and other characteristic comparisons of seroprevalence, proportion of undiagnosed HIV infection, proportion of HIV viral suppression, and proportion with presence of antiretrovirals was performed across serosurveys by x 2 -square test or Fisher's exact test for proportions using SAS 9.4 (SAS Institute Inc., Cary, North Carolina, USA). Mean population HIV viral load for each serosurvey in which it was assayed was calculated as antilogarithm of the mean of logarithm to the base 10 of each viral load. The comparison of HIV viral load by serosurvey was performed using nonparametric Wilcoxon rank-sum test. Viral suppression was defined as a viral load less than 400 copies/ml, the limit of detection for the assay used. The proportion of infected patients with viral suppression was compared using Cochran Armitage Trend test. LTC was calculated as presence at a follow-up appointment within 30 and 90 days of testing. LTC rates were calculated as a simple proportion.
Results
A total of 18 144 patients were included in the seven identity-unlinked seroprevalence studies between 1987 and 2013. Table 1 shows the demographic characteristics of the population by the study year. The study population was slightly older, had a slightly higher proportion of women, and decreased proportion of black patients in recent years as compared to earlier years (P < 0.05, respectively). Cross-sectional annual HIV incidence estimates in 2001 were 2.28% (95% CI: 0.69-3.85%) which declined steadily to 0.99% (95% CI: 0.14-1.84%) in 2003, 0.46% (95% CI: 0.01-0.91%) in 2007, and 0.16% (95% CI: 0-0.39%) by 2013 (Fig. 2) .
The proportion of HIV-infected individuals with viral suppression (<400 copies/ml) increased steadily from 23% in both 2001 and 2003, to 32% in 2007, and 59% by 2013 (P < 0.001, Cochran Armitage Trend test) (Fig. 2) . The mean viral load was 8128 copies/ml (95% CI: 5370-12 302) in 2001, increased to 10 964 (95% CI: 7586-15 849) in 2003, then significantly declined to 4677 (95% CI: 3388-6456) in 2007, and further decreased to 1318 (95% CI: 933-1862) in 2013 (P < 0.001; Table 2 ). The temporal trend in decreased viral load was consistent in all demographic subgroups (P < 0.05), except those aged 35 and under (P ¼ 0.10).
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AIDS 2016, Vol 30 No 1 patients tested were newly diagnosed with HIV and only seven (32%) of those eligible (three were not eligible) were linked to care within 30 days, although 77% were linked to care within 90 days. In 2013, 0.4% (25 of 6797) patients tested were newly diagnosed; 72% and 88% were linked to care within 30, and 90 days, respectively.
Discussion
Since the early days of the HIV epidemic, EDs have often been the point of first medical contact for HIV-infected persons, and consequently, have played a key role in strategic initiatives to counter the epidemic. Initially, EDs helped characterize the extent of the epidemic at the local population level. As it became apparent that vulnerable and at risk populations utilized EDs [27, 28] as their sole point of entry into the health system [29] , EDs started investigating the feasibility of point of care screening in this busy setting. These early programs demonstrated considerable effectiveness for early detection of HIV, and by 2006, the CDC identified EDs as key sites for early detection of HIV [30] . This eventually led to the formation of the National Emergency Department HIV-Testing Consortium, formed to promote ED-based HIV screening [31] . As a result, HIV-screening activity in EDs across the USA increased. In 2004, less than 2% of EDs offered HIV screening [32] , but by 2009, a quarter of EDs offered some type of organized HIV-screening program [33] .
In analyzing trends over the last 25 years in our inner-city ED, we have been able to document major changes in HIV prevalence, knowledge of HIV status, improved access to antiretroviral drugs with enhanced viral suppression and a consequential reduction in incidence among patients from the local community of Baltimore. Simultaneously there has been an observed significant downward trend in number of new HIV cases reported in Baltimore City in the last decade (new reported HIV cases: 1052 in 2007 and 356 in 2013) [34] . These positive signs in access to care among HIV positive individuals are in direct contrast to the early days of the epidemic when most individuals did not even know their HIV status. From the 1980s through the early 1990s, our ED continuously reported the highest rates of HIV infection among the population it served [8] [9] [10] . Now, it appears that the overall prevalence of HIV infection peaked a decade ago ( Fig. 1) and is on the decline. Furthermore, our data on HIV prevalence by gender and race, particularly in black men, mirrors the overall HIV CI, confidence interval. a P-value for the distribution of HIV viral load in 2013 compared with previous survey years less than 0.001. b P-value by the Cochran Armitage Trend test for proportion of HIV viral load less than 400 copies/ml (undetectable level) by study year was less than 0.001. c P-value by the Cochran Armitage Trend test for proportion of HIV viral load more than 10 000 copies/ml (high viral load level) by study year was less than 0.001. burden over time observed by race and sex in Baltimore City [35] , in Maryland, and nationally [36] . The declining prevalence and cross-sectional annual incidence of HIV in this ED population observed over the last 10 years ( Figs. 1  and 3) , likely reflects the marked improvement in diagnosis and access to care in the community, the marked increase in antiretroviral use as indicated in our survey, decrease in unrecognized HIV, there were fewer symptomatic HIV individuals attending the ED which would result in a lowering in HIV prevalence, as well as the influence of needle exchange programs and other behavior interventions [37] [38] [39] . We have also seen a similar decline in hepatitis C virus prevalence during this time period (unpublished data). These findings are supported by the marked decline in undiagnosed HIV from 77% in 1987 to only 7% in 2013, a remarkable achievement in the promotion of routine screening and early diagnosis, which increased nearly 300% by 2013 for an annualized rate of testing nearly 7000 patients [22] .
In addition to screening and early detection, EDs have also seized an important role in the early stages of linking HIV-infected patients to care (LTC) by partnering with public health and HIV practitioners. Indeed, Gardner and colleagues identified LTC as integral to a 5-step optimal HIV spectrum of care (HIV diagnosis, LTC, retained in care, treatment with antiretrovirals, viral suppression). Hsieh et al. [13] , also emphasized the important role of the ED by reestablishing 'linkage' for those who originally failed to establish LTC and those who had fallen out of care [40] . This entire spectrum of care became known as the HIV Care Continuum Initiative (HIV CCI), after an executive order issued by President Obama 2013 intended to accelerate improvements in HIV prevention and care across the United States [41] .
Of particular interest in our population is the proportionate increase of antiretroviral use among HIV-infected individuals from 2007 to 2013 (from 27% to 80%). Although improved treatment may be due to a variety of influences, our observed improvement in LTC at 30 and 90 days (from 32 to 72% and 77 to 88%, respectively) might have contributed to increased antiretroviral use, which undoubtedly influenced the improvement in overall viral suppression. Another positive influence in increased antiretroviral treatment in our population was the change in the national guidelines to treat all HIVinfected individuals regardless of CD4 þ cell counts, recommendations followed by our local referral clinics [42] .
Achieving LTC and ultimately viral suppression can be particularly challenging in inner-city EDs such as ours. However, with active procedures and leveraging critical infrastructure intrinsic to EDs (e.g. close partnering with on-site clinics with use of on-site case management) emergency, we, and others, have achieved LTC rates near, and even over 90% [43] [44] [45] , which is significantly higher than the national norm of 76% [46] . Gardner et al. suggested 90% achievement at each stage as necessary for a meaningful level of intervention, but this would still leave over a third of infected individuals viremic [47] . Based on data available prior to 2011, Gardner et al. estimated that, nationally, only 19% of HIV-infected individuals reached succeeded in achieving viral suppression. Thus, the achievement of 59% of viral suppression noted here in 2013 (significantly increased from 23% and 32% in 2001 and 2007 respectively) is one of the highest rates of viral suppression reported by any ED and near the best scenario (66%) simulated by Gardner [47] .
Although causation cannot be implied by these data given all the factors that may influence improved HIV incidence, detection and care (e.g. needle exchange programs, primary behavioral intervention programs in the community) [37] [38] [39] , it is noted that the significantly . However, to the best of our knowledge the JHH program is the largest and the only sustained program over this time period. Data on antiretroviral treatment is not based on patient reporting, which is subject to bias, but rather is based on a direct measurement of antiretrovirals in sera in all HIV-positive individuals. Additional support for LTC and antiretroviral use is the significant increase in viral suppression and antiretroviral use which increased from 27% in 2007 to 80% in 2013, that is, during the same time period. This level of suppression was similar to observations seen in other populations followed at Johns Hopkins Clinics, such as injecting drug users from the ALIVE cohort [48] , and patients attending the JHH Moore HIV Care clinic [49] .
Our report has several limitations. There were some changes in the demographic distribution of the ED population over time and this may have had some impact on changes in HIV prevalence. Furthermore, data such as sexual behavior or parenteral drug use was not systematically collected over time. As parenteral drug users and men who have sex with men in Baltimore have been reported to have high prevalence of HIV infection [35] , changes in their attendance to the ED would possibly affect our overall prevalence. However, this limitation would not necessarily directly affect our results on LTC, antiretroviral use, or viral suppression. As noted, we are not implying causation, but our programmatic efforts parallel the outcomes. It may be argued that the data presented here are not generalizable given some of the unique characteristics of the local population that has among the highest rates of HIV infection. Nonetheless, the overall data parallel national trends, and the role of EDs in high prevalence settings are underscored in the importance of screening and LTC as a critical part of the continuum of care.
With readily available treatment, early diagnosis is the key to initiating the LTC, starting antiretrovirals and ensuring viral suppression that could result in lower transmission rates and ultimately lower incidence of HIV in the population. HIV testing among the ED attendees offer opportunity to provide prevention messages among the HIV negative population, further supporting the national HIV prevention strategy, as is reengaging HIV individuals who failed LTC or left care previously. Collectively, our data on the declining prevalence and incidence, improved knowledge of HIV status, increased presence of antiretrovirals among those infected, and viral suppression in nearly 60% of infected individuals provide encouragement for prevention programs in the community, including the role of EDs in HIV continuum of care within Baltimore City and the population that the JHH ED serves.
